Skip to main navigation Skip to search Skip to main content

Study of the Antiviral Efficacy and Safety of Atazanavir in Combination with Ritonavir or Saquinavir and the Combination of Lopinavir/Ritonavir Each With Tenofovir and Nucleoside in Subjects who Have Experienced Virologic Failure

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/0112/31/08

Funding

  • Bristol Myers Squibb Company: $31,663.00